cryotherapy
Procedure1-2 times during the treatment time
NCT Number: NCT01358851
The aim of this study is to evaluate the efficacy and safety of LAS 41005 compared to cryotherapy in subjects with moderate to severe hyperkeratotic actinic keratosis (punch biopsies).
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Phase 2
Almirall investigative site 3, Dülmen, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Main Inclusion Criteria:
Main Exclusion Criteria:
1-2 times during the treatment time
once daily
Time frame: Screening and 8 weeks after last treatment
Histological clearance at 8 weeks after end of treatment with LAS 41005, respectively 14 weeks after first cryotherapy. Histological Status will be measured by Histological Biopsy in order to confirm the diagnosis of AK and the grade.
Time frame: day 1, day 21, day 42 and day 98.
The clearance rate (complete/partial) of AK lesions (determined by clinical evaluation) in the treatment area (target areas A and B) will be measured by comparing the total AK lesion counts pre-treatment (on Day 1 before study treatment has been applied) with the lesion counts measured.
Almirall, S.A.
Industry
A Prospective Comparator Controlled Randomized Exploratory Study on the Efficacy of LAS 41005 Compared to Cryotherapy in Subjects With Hyperkeratotic Actinic Keratosis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06888362
Actinic Keratosis, Keratosis
Uppsala, Sweden
View Trial DetailsNCT06027619
Actinic Keratosis, Keratosis
Cleveland, Ohio, United States
View Trial DetailsNCT06319794
Actinic Keratosis, Keratosis
Basel, Switzerland
View Trial DetailsNCT00472459
Actinic Keratosis, Basal Cell Carcinoma
Aarhus, Denmark
View Trial Details